Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
ATP-Binding Cassette Transporters | 16 | 2013 | 560 | 2.400 |
Why?
|
Pyrans | 5 | 2023 | 54 | 1.950 |
Why?
|
Metformin | 3 | 2023 | 835 | 1.500 |
Why?
|
Cholesterol | 16 | 2011 | 2917 | 1.120 |
Why?
|
Receptors, Immunologic | 12 | 2005 | 1423 | 1.090 |
Why?
|
Arteriosclerosis | 10 | 2005 | 1092 | 1.010 |
Why?
|
Apolipoprotein A-I | 9 | 2008 | 281 | 0.980 |
Why?
|
Deglutition Disorders | 2 | 2019 | 605 | 0.930 |
Why?
|
Lipoproteins, LDL | 13 | 2006 | 640 | 0.860 |
Why?
|
Macrophages | 17 | 2008 | 5655 | 0.840 |
Why?
|
Aldosterone | 2 | 2022 | 877 | 0.760 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 6 | 2003 | 871 | 0.760 |
Why?
|
Receptors, Lipoprotein | 6 | 2002 | 81 | 0.720 |
Why?
|
Hypertension | 4 | 2023 | 8480 | 0.650 |
Why?
|
Receptors, Scavenger | 13 | 2006 | 121 | 0.650 |
Why?
|
Urination Disorders | 1 | 2019 | 241 | 0.640 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2023 | 11725 | 0.640 |
Why?
|
Renal Insufficiency | 1 | 2024 | 804 | 0.620 |
Why?
|
Hypoglycemic Agents | 6 | 2023 | 2872 | 0.600 |
Why?
|
Scavenger Receptors, Class A | 7 | 2008 | 54 | 0.570 |
Why?
|
Myositis | 1 | 2019 | 251 | 0.560 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2046 | 0.550 |
Why?
|
Foam Cells | 5 | 2008 | 71 | 0.520 |
Why?
|
Muscular Diseases | 1 | 2019 | 556 | 0.510 |
Why?
|
Cholesterol, HDL | 6 | 2007 | 1814 | 0.500 |
Why?
|
Glucosylceramides | 1 | 2013 | 28 | 0.470 |
Why?
|
Double-Blind Method | 8 | 2023 | 12026 | 0.460 |
Why?
|
Hyperlipidemias | 3 | 2008 | 789 | 0.460 |
Why?
|
Glucosylceramidase | 1 | 2013 | 124 | 0.440 |
Why?
|
Tangier Disease | 5 | 2011 | 11 | 0.440 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2208 | 0.410 |
Why?
|
Lipid Metabolism | 4 | 2006 | 1889 | 0.410 |
Why?
|
Ceramides | 2 | 2013 | 199 | 0.410 |
Why?
|
Lipopolysaccharides | 7 | 2005 | 2216 | 0.400 |
Why?
|
Macrophages, Peritoneal | 6 | 2005 | 251 | 0.390 |
Why?
|
Epidermis | 1 | 2013 | 528 | 0.370 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 3255 | 0.350 |
Why?
|
Mice, Knockout | 19 | 2013 | 14557 | 0.330 |
Why?
|
Area Under Curve | 2 | 2023 | 1654 | 0.320 |
Why?
|
Kidney Diseases | 1 | 2019 | 2149 | 0.320 |
Why?
|
Microarray Analysis | 3 | 2006 | 767 | 0.310 |
Why?
|
Esters | 1 | 2008 | 210 | 0.310 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2133 | 0.300 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4931 | 0.300 |
Why?
|
Phosphatidylglycerols | 1 | 2006 | 34 | 0.290 |
Why?
|
Macrophage Activation | 3 | 2004 | 558 | 0.280 |
Why?
|
Pulmonary Surfactants | 1 | 2006 | 162 | 0.280 |
Why?
|
Dystrophin-Associated Proteins | 1 | 2005 | 61 | 0.270 |
Why?
|
Cholesterol Esters | 1 | 2005 | 73 | 0.270 |
Why?
|
Apolipoproteins E | 5 | 2008 | 1438 | 0.250 |
Why?
|
Antigens, Differentiation | 2 | 2004 | 927 | 0.240 |
Why?
|
Atherosclerosis | 4 | 2008 | 3445 | 0.240 |
Why?
|
Mice | 37 | 2021 | 81183 | 0.230 |
Why?
|
Receptors, LDL | 4 | 1998 | 475 | 0.230 |
Why?
|
Lipids | 4 | 2013 | 3305 | 0.230 |
Why?
|
Receptors, Cell Surface | 6 | 2005 | 2866 | 0.230 |
Why?
|
Signal Transduction | 10 | 2005 | 23403 | 0.230 |
Why?
|
Phosphatidylcholines | 1 | 2004 | 411 | 0.220 |
Why?
|
Immunity, Innate | 2 | 2005 | 2958 | 0.210 |
Why?
|
Bile Acids and Salts | 2 | 2002 | 367 | 0.210 |
Why?
|
Animals | 50 | 2021 | 168757 | 0.210 |
Why?
|
Blood Glucose | 3 | 2023 | 6256 | 0.210 |
Why?
|
Apolipoproteins | 1 | 2003 | 317 | 0.200 |
Why?
|
Membrane Glycoproteins | 5 | 2005 | 3768 | 0.200 |
Why?
|
Membrane Proteins | 6 | 2002 | 7880 | 0.190 |
Why?
|
Blood Pressure | 3 | 2022 | 8554 | 0.190 |
Why?
|
Mice, Inbred C57BL | 18 | 2021 | 21827 | 0.190 |
Why?
|
Scavenger Receptors, Class B | 6 | 2002 | 81 | 0.180 |
Why?
|
Myoglobinuria | 1 | 2019 | 23 | 0.180 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2000 | 134 | 0.180 |
Why?
|
Humans | 55 | 2024 | 744343 | 0.170 |
Why?
|
Nitric Oxide Synthase | 1 | 2022 | 916 | 0.170 |
Why?
|
Heterozygote | 3 | 2008 | 2804 | 0.170 |
Why?
|
Protein Binding | 6 | 2008 | 9386 | 0.170 |
Why?
|
Statistics, Nonparametric | 1 | 2005 | 2886 | 0.170 |
Why?
|
Lipoproteins | 3 | 2000 | 878 | 0.170 |
Why?
|
Rhabdomyolysis | 1 | 2019 | 150 | 0.160 |
Why?
|
Drug Interactions | 1 | 2023 | 1460 | 0.160 |
Why?
|
Respiratory Insufficiency | 1 | 2006 | 1199 | 0.160 |
Why?
|
Inflammation | 5 | 2008 | 10638 | 0.160 |
Why?
|
Cross-Over Studies | 1 | 2023 | 2029 | 0.150 |
Why?
|
Carotid Artery, Internal | 1 | 2019 | 445 | 0.140 |
Why?
|
Hypercholesterolemia | 5 | 2007 | 1151 | 0.140 |
Why?
|
Gene Expression Regulation | 5 | 2008 | 12072 | 0.140 |
Why?
|
Transcription Factors | 5 | 2004 | 12208 | 0.140 |
Why?
|
Muscle Weakness | 1 | 2019 | 413 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 4 | 2005 | 1504 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 2 | 2002 | 1836 | 0.140 |
Why?
|
Cardiovascular System | 1 | 2023 | 832 | 0.140 |
Why?
|
Glomerular Filtration Rate | 1 | 2024 | 2170 | 0.140 |
Why?
|
Mutation | 9 | 2011 | 29786 | 0.140 |
Why?
|
Cell Line | 11 | 2005 | 15997 | 0.130 |
Why?
|
Transfection | 5 | 2005 | 5892 | 0.130 |
Why?
|
Biotechnology | 1 | 2017 | 281 | 0.130 |
Why?
|
Biological Transport, Active | 2 | 2005 | 349 | 0.130 |
Why?
|
Hydrocortisone | 1 | 2022 | 1826 | 0.120 |
Why?
|
Ligands | 4 | 2003 | 3282 | 0.120 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2716 | 0.120 |
Why?
|
Cerebral Infarction | 1 | 2019 | 1011 | 0.120 |
Why?
|
Chromatography, Thin Layer | 1 | 2013 | 223 | 0.120 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6489 | 0.120 |
Why?
|
Emigration and Immigration | 1 | 2017 | 404 | 0.120 |
Why?
|
Diet, Atherogenic | 3 | 2005 | 95 | 0.110 |
Why?
|
Hyperkalemia | 1 | 2015 | 218 | 0.110 |
Why?
|
Promoter Regions, Genetic | 3 | 2000 | 5867 | 0.110 |
Why?
|
Amyloid beta-Peptides | 2 | 2003 | 3587 | 0.110 |
Why?
|
Lasers, Solid-State | 2 | 2012 | 169 | 0.110 |
Why?
|
Metabolism, Inborn Errors | 1 | 2015 | 288 | 0.110 |
Why?
|
Adipose Tissue | 1 | 2004 | 3279 | 0.110 |
Why?
|
Gene Deletion | 1 | 2000 | 2751 | 0.110 |
Why?
|
Receptors, Leukotriene B4 | 2 | 2005 | 94 | 0.110 |
Why?
|
Hyperlipoproteinemia Type II | 2 | 2015 | 373 | 0.110 |
Why?
|
Escherichia coli | 2 | 2005 | 4217 | 0.110 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1442 | 0.110 |
Why?
|
Public Policy | 1 | 2017 | 572 | 0.110 |
Why?
|
Fibroblasts | 4 | 2002 | 4161 | 0.110 |
Why?
|
Diffusion of Innovation | 1 | 2017 | 725 | 0.100 |
Why?
|
Glycoproteins | 1 | 2000 | 2263 | 0.100 |
Why?
|
Protein Structure, Tertiary | 3 | 2004 | 3846 | 0.100 |
Why?
|
Biological Transport | 4 | 2011 | 2118 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2012 | 2038 | 0.100 |
Why?
|
Aged | 12 | 2019 | 163280 | 0.100 |
Why?
|
Mice, Transgenic | 3 | 2002 | 9734 | 0.100 |
Why?
|
Enzyme Inhibitors | 1 | 2022 | 3798 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Kidney | 2 | 2024 | 7186 | 0.100 |
Why?
|
Technology Transfer | 1 | 2011 | 44 | 0.100 |
Why?
|
Immunohistochemistry | 6 | 2013 | 11366 | 0.100 |
Why?
|
Organ Culture Techniques | 1 | 2013 | 813 | 0.100 |
Why?
|
Female | 25 | 2021 | 380194 | 0.100 |
Why?
|
Potassium | 1 | 2015 | 1336 | 0.100 |
Why?
|
Coronary Disease | 1 | 2006 | 6077 | 0.100 |
Why?
|
Program Development | 1 | 2017 | 1316 | 0.100 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13815 | 0.090 |
Why?
|
Therapeutics | 1 | 2011 | 116 | 0.090 |
Why?
|
Papilloma | 1 | 2011 | 148 | 0.090 |
Why?
|
Cell Differentiation | 6 | 2002 | 11483 | 0.090 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 257 | 0.090 |
Why?
|
Mixed Function Oxygenases | 1 | 2011 | 272 | 0.090 |
Why?
|
Protein Sorting Signals | 2 | 1989 | 281 | 0.090 |
Why?
|
Immunoblotting | 1 | 2013 | 1682 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2022 | 10943 | 0.090 |
Why?
|
Dendritic Cells | 1 | 2001 | 2725 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3176 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2008 | 9438 | 0.090 |
Why?
|
Models, Statistical | 1 | 2005 | 5102 | 0.090 |
Why?
|
Molecular Sequence Data | 8 | 2004 | 18111 | 0.090 |
Why?
|
Cell Adhesion Molecules | 2 | 1993 | 1602 | 0.090 |
Why?
|
Adenoviridae | 3 | 2003 | 1099 | 0.090 |
Why?
|
Models, Genetic | 3 | 2011 | 3494 | 0.090 |
Why?
|
DNA | 4 | 2002 | 7301 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2001 | 1095 | 0.080 |
Why?
|
Industry | 1 | 2011 | 365 | 0.080 |
Why?
|
NF-kappa B | 4 | 2005 | 2499 | 0.080 |
Why?
|
Macrophage-1 Antigen | 2 | 2000 | 290 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 3 | 2004 | 3772 | 0.080 |
Why?
|
Tyrosine | 2 | 2003 | 1461 | 0.080 |
Why?
|
Toll-Like Receptors | 4 | 2005 | 592 | 0.080 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 1518 | 0.080 |
Why?
|
Serine C-Palmitoyltransferase | 1 | 2008 | 39 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 4 | 2005 | 565 | 0.080 |
Why?
|
Laryngeal Diseases | 1 | 2011 | 241 | 0.080 |
Why?
|
Diabetic Nephropathies | 1 | 2015 | 984 | 0.080 |
Why?
|
Recombinant Proteins | 3 | 2005 | 6622 | 0.080 |
Why?
|
Polymers | 1 | 2015 | 1621 | 0.080 |
Why?
|
Skin | 2 | 2013 | 4364 | 0.080 |
Why?
|
Phagocytosis | 3 | 2002 | 1539 | 0.080 |
Why?
|
Treatment Outcome | 5 | 2023 | 63114 | 0.080 |
Why?
|
Linoleic Acid | 1 | 2008 | 157 | 0.080 |
Why?
|
Parathyroid Hormone | 3 | 1992 | 1801 | 0.080 |
Why?
|
RNA | 2 | 2008 | 2749 | 0.080 |
Why?
|
Aorta | 4 | 2008 | 2061 | 0.080 |
Why?
|
Cells, Cultured | 9 | 2004 | 19229 | 0.080 |
Why?
|
Adult | 11 | 2023 | 214055 | 0.070 |
Why?
|
Dyslipidemias | 1 | 2015 | 849 | 0.070 |
Why?
|
Lipoproteins, HDL | 3 | 2000 | 638 | 0.070 |
Why?
|
HEK293 Cells | 2 | 2013 | 4204 | 0.070 |
Why?
|
Luminescent Proteins | 2 | 2001 | 853 | 0.070 |
Why?
|
Vocal Cords | 1 | 2011 | 528 | 0.070 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3920 | 0.070 |
Why?
|
Protein Precursors | 2 | 1989 | 1154 | 0.070 |
Why?
|
Reactive Oxygen Species | 3 | 2003 | 2077 | 0.070 |
Why?
|
Particle Size | 3 | 2000 | 1642 | 0.070 |
Why?
|
Permeability | 1 | 2008 | 738 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2003 | 4420 | 0.070 |
Why?
|
Research Personnel | 1 | 2011 | 573 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.070 |
Why?
|
Copper | 2 | 2002 | 366 | 0.070 |
Why?
|
RNA, Messenger | 5 | 2008 | 13033 | 0.070 |
Why?
|
Gene Expression | 4 | 2005 | 7799 | 0.070 |
Why?
|
Drug Design | 1 | 2011 | 1076 | 0.070 |
Why?
|
Luciferases | 2 | 2000 | 733 | 0.070 |
Why?
|
Universities | 1 | 2011 | 956 | 0.070 |
Why?
|
Male | 22 | 2021 | 350118 | 0.070 |
Why?
|
Sinus of Valsalva | 1 | 2005 | 59 | 0.060 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6386 | 0.060 |
Why?
|
Liver | 1 | 2001 | 7474 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2004 | 33 | 0.060 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2011 | 1121 | 0.060 |
Why?
|
Base Sequence | 6 | 2001 | 12797 | 0.060 |
Why?
|
Cell Line, Transformed | 2 | 2003 | 898 | 0.060 |
Why?
|
Microscopy, Electron | 1 | 2008 | 2645 | 0.060 |
Why?
|
Middle Aged | 12 | 2019 | 213383 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 2012 | 961 | 0.060 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 1998 | 294 | 0.060 |
Why?
|
Escherichia coli K12 | 1 | 2004 | 34 | 0.060 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 712 | 0.060 |
Why?
|
Fenofibrate | 1 | 2005 | 88 | 0.060 |
Why?
|
Microglia | 2 | 2003 | 1266 | 0.060 |
Why?
|
Leukotriene B4 | 1 | 2005 | 294 | 0.060 |
Why?
|
DNA Probes | 2 | 2006 | 560 | 0.060 |
Why?
|
Green Fluorescent Proteins | 2 | 2001 | 2088 | 0.060 |
Why?
|
Receptors, Purinergic P2 | 1 | 2005 | 153 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15165 | 0.060 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2005 | 687 | 0.060 |
Why?
|
Carrier Proteins | 4 | 2005 | 5021 | 0.060 |
Why?
|
Homozygote | 2 | 2006 | 1785 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12959 | 0.060 |
Why?
|
Temperature | 2 | 2002 | 2206 | 0.060 |
Why?
|
Crosses, Genetic | 2 | 2002 | 791 | 0.060 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2004 | 123 | 0.060 |
Why?
|
Sequence Deletion | 2 | 2005 | 1526 | 0.060 |
Why?
|
Azetidines | 1 | 2005 | 142 | 0.060 |
Why?
|
Cell Membrane | 3 | 2003 | 3748 | 0.060 |
Why?
|
Genotype | 3 | 2011 | 12951 | 0.060 |
Why?
|
Phosphorylation | 3 | 2004 | 8436 | 0.060 |
Why?
|
Teichoic Acids | 1 | 2003 | 66 | 0.060 |
Why?
|
Cytokines | 5 | 2005 | 7322 | 0.060 |
Why?
|
Warfarin | 1 | 2011 | 1496 | 0.060 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2004 | 571 | 0.060 |
Why?
|
Peritonitis | 2 | 2002 | 365 | 0.060 |
Why?
|
Phospholipids | 1 | 2006 | 784 | 0.060 |
Why?
|
3T3 Cells | 1 | 2004 | 1101 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2005 | 936 | 0.050 |
Why?
|
Genes, Reporter | 2 | 1998 | 1547 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2002 | 116 | 0.050 |
Why?
|
Salmonella Infections, Animal | 1 | 2002 | 65 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2008 | 18029 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11727 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2015 | 3597 | 0.050 |
Why?
|
Drosophila Proteins | 2 | 2002 | 1703 | 0.050 |
Why?
|
Cyclic AMP | 2 | 1999 | 1472 | 0.050 |
Why?
|
Transduction, Genetic | 2 | 2003 | 913 | 0.050 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2002 | 361 | 0.050 |
Why?
|
Peptides | 2 | 2004 | 4409 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 829 | 0.050 |
Why?
|
Models, Chemical | 1 | 2004 | 626 | 0.050 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2002 | 130 | 0.050 |
Why?
|
Acute-Phase Proteins | 1 | 2002 | 262 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2004 | 2256 | 0.050 |
Why?
|
Animals, Newborn | 1 | 2006 | 2726 | 0.050 |
Why?
|
Macromolecular Substances | 1 | 2003 | 1454 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 480 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 489 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2002 | 375 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2011 | 2759 | 0.050 |
Why?
|
Protein Biosynthesis | 3 | 2001 | 2126 | 0.050 |
Why?
|
Papillomavirus Infections | 1 | 2012 | 1587 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 604 | 0.050 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2000 | 279 | 0.050 |
Why?
|
Oxandrolone | 1 | 1980 | 23 | 0.050 |
Why?
|
Lipid Bilayers | 1 | 2002 | 381 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 1992 | 4456 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2008 | 3505 | 0.040 |
Why?
|
Mutagenesis | 1 | 2004 | 1266 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 10900 | 0.040 |
Why?
|
src-Family Kinases | 1 | 2002 | 551 | 0.040 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2000 | 165 | 0.040 |
Why?
|
Intestinal Absorption | 1 | 2001 | 420 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 915 | 0.040 |
Why?
|
Receptors, Lipoxin | 1 | 1999 | 84 | 0.040 |
Why?
|
Multiprotein Complexes | 1 | 2005 | 1119 | 0.040 |
Why?
|
Bacterial Adhesion | 1 | 2000 | 316 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 2002 | 694 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2000 | 374 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5720 | 0.040 |
Why?
|
Receptors, Formyl Peptide | 1 | 1999 | 145 | 0.040 |
Why?
|
Gene Silencing | 1 | 2005 | 1538 | 0.040 |
Why?
|
Blotting, Western | 2 | 2007 | 5179 | 0.040 |
Why?
|
Hydroxyeicosatetraenoic Acids | 1 | 1999 | 226 | 0.040 |
Why?
|
Collagen | 2 | 1998 | 2689 | 0.040 |
Why?
|
Genetic Markers | 1 | 2004 | 2634 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1009 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 2000 | 655 | 0.040 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2000 | 404 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4740 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2001 | 2050 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 1285 | 0.040 |
Why?
|
CHO Cells | 3 | 2011 | 1406 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 1998 | 396 | 0.040 |
Why?
|
Polysaccharides | 1 | 2003 | 1053 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2004 | 2916 | 0.040 |
Why?
|
Lipoxins | 1 | 1999 | 412 | 0.040 |
Why?
|
Binding Sites | 1 | 2005 | 6114 | 0.040 |
Why?
|
Glucose | 1 | 2008 | 4397 | 0.030 |
Why?
|
COS Cells | 1 | 1998 | 1161 | 0.030 |
Why?
|
Dependovirus | 1 | 2021 | 706 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 288 | 0.030 |
Why?
|
Cell Movement | 3 | 2005 | 5217 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20129 | 0.030 |
Why?
|
Cricetinae | 3 | 2011 | 2472 | 0.030 |
Why?
|
Genetic Vectors | 2 | 2000 | 3420 | 0.030 |
Why?
|
Models, Biological | 2 | 2002 | 9583 | 0.030 |
Why?
|
Antigens, CD | 2 | 1998 | 4026 | 0.030 |
Why?
|
Pedigree | 2 | 2000 | 4644 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2000 | 1041 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 3870 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2000 | 1179 | 0.030 |
Why?
|
Biotransformation | 1 | 2015 | 168 | 0.030 |
Why?
|
Models, Molecular | 1 | 2005 | 5456 | 0.030 |
Why?
|
Glycosylation | 1 | 1998 | 1126 | 0.030 |
Why?
|
Population Dynamics | 1 | 2017 | 302 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2375 | 0.030 |
Why?
|
Adipocytes | 1 | 2002 | 1184 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2015 | 379 | 0.030 |
Why?
|
Human Genome Project | 1 | 2015 | 193 | 0.030 |
Why?
|
Immunologic Memory | 1 | 2021 | 1348 | 0.030 |
Why?
|
Weight Gain | 1 | 2004 | 2292 | 0.030 |
Why?
|
Proteins | 2 | 2004 | 6103 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2000 | 6314 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2000 | 1341 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2000 | 1701 | 0.030 |
Why?
|
Haplotypes | 1 | 2000 | 2779 | 0.030 |
Why?
|
Time Factors | 4 | 2002 | 40075 | 0.030 |
Why?
|
Dehydroascorbic Acid | 1 | 1993 | 2 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1483 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 798 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2002 | 2564 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2002 | 3200 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2008 | 10481 | 0.030 |
Why?
|
Lung | 3 | 2006 | 9856 | 0.030 |
Why?
|
Neutrophils | 2 | 2002 | 3719 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 1999 | 1026 | 0.030 |
Why?
|
Reference Values | 1 | 2000 | 4982 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3299 | 0.030 |
Why?
|
Anticholesteremic Agents | 1 | 1980 | 979 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2004 | 3188 | 0.030 |
Why?
|
Cloning, Molecular | 2 | 1995 | 4320 | 0.030 |
Why?
|
Inositol Phosphates | 1 | 1992 | 180 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 1993 | 270 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2002 | 5974 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1202 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1992 | 821 | 0.020 |
Why?
|
Alleles | 1 | 2002 | 6933 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 2 | 2011 | 1990 | 0.020 |
Why?
|
Oxygen | 1 | 2002 | 4189 | 0.020 |
Why?
|
Mice, Inbred CBA | 2 | 2002 | 448 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2015 | 759 | 0.020 |
Why?
|
Cytoplasm | 1 | 1995 | 1539 | 0.020 |
Why?
|
American Heart Association | 1 | 2015 | 1056 | 0.020 |
Why?
|
Monocytes | 1 | 2000 | 2596 | 0.020 |
Why?
|
Protein Conformation | 1 | 1998 | 4011 | 0.020 |
Why?
|
Phonation | 1 | 2011 | 219 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2011 | 367 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2002 | 4554 | 0.020 |
Why?
|
Nomograms | 1 | 2011 | 228 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2004 | 9648 | 0.020 |
Why?
|
Membrane Microdomains | 1 | 2011 | 203 | 0.020 |
Why?
|
Membrane Lipids | 1 | 2011 | 248 | 0.020 |
Why?
|
Rabbits | 2 | 1995 | 4894 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1375 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 1993 | 651 | 0.020 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1993 | 1663 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 816 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 7913 | 0.020 |
Why?
|
Cardiovascular Agents | 1 | 2015 | 850 | 0.020 |
Why?
|
Injections | 1 | 2011 | 840 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10180 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3913 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2011 | 675 | 0.020 |
Why?
|
Aspirin | 1 | 1999 | 3282 | 0.020 |
Why?
|
Sterol O-Acyltransferase | 1 | 2007 | 27 | 0.020 |
Why?
|
Cholesterol, LDL | 2 | 2007 | 2356 | 0.020 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2008 | 194 | 0.020 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2007 | 212 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9959 | 0.020 |
Why?
|
Survival Analysis | 1 | 2000 | 10252 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6487 | 0.020 |
Why?
|
Cattle | 1 | 1992 | 3922 | 0.020 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2007 | 91 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2951 | 0.020 |
Why?
|
Stem Cells | 1 | 1998 | 3567 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2004 | 77 | 0.020 |
Why?
|
Receptors, CCR2 | 1 | 2005 | 212 | 0.020 |
Why?
|
Cholesterol, Dietary | 1 | 2004 | 231 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2005 | 964 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1736 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2004 | 1157 | 0.010 |
Why?
|
Neutrophil Infiltration | 1 | 2005 | 390 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 2002 | 203 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 2002 | 192 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2003 | 8037 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 425 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2005 | 669 | 0.010 |
Why?
|
Tryptophan | 1 | 2004 | 478 | 0.010 |
Why?
|
Toll-Like Receptor 9 | 1 | 2002 | 212 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15540 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16689 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2004 | 1246 | 0.010 |
Why?
|
Chemokine CCL2 | 1 | 2003 | 617 | 0.010 |
Why?
|
Viral Fusion Proteins | 1 | 2000 | 95 | 0.010 |
Why?
|
Syndrome | 1 | 2007 | 3251 | 0.010 |
Why?
|
Toll-Like Receptor 2 | 1 | 2002 | 354 | 0.010 |
Why?
|
Salmonella typhimurium | 1 | 2002 | 351 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8642 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6473 | 0.010 |
Why?
|
Serine | 1 | 2004 | 826 | 0.010 |
Why?
|
Chemotaxis | 1 | 2003 | 607 | 0.010 |
Why?
|
Gene Transfer, Horizontal | 1 | 2000 | 145 | 0.010 |
Why?
|
Transcription, Genetic | 2 | 2000 | 7722 | 0.010 |
Why?
|
Dactinomycin | 1 | 2000 | 318 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 370 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3340 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8340 | 0.010 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2003 | 1263 | 0.010 |
Why?
|
Plaque, Amyloid | 1 | 2003 | 729 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1791 | 0.010 |
Why?
|
Exudates and Transudates | 1 | 1999 | 172 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1730 | 0.010 |
Why?
|
Lipoproteins, VLDL | 1 | 1980 | 201 | 0.010 |
Why?
|
Arachidonate 5-Lipoxygenase | 1 | 1999 | 144 | 0.010 |
Why?
|
Half-Life | 1 | 2000 | 661 | 0.010 |
Why?
|
Chemokines | 1 | 2003 | 970 | 0.010 |
Why?
|
HL-60 Cells | 1 | 1999 | 365 | 0.010 |
Why?
|
Ear, External | 1 | 1999 | 161 | 0.010 |
Why?
|
Calcium | 1 | 1992 | 5756 | 0.010 |
Why?
|
Triglycerides | 1 | 2006 | 2454 | 0.010 |
Why?
|
Lipase | 1 | 2000 | 314 | 0.010 |
Why?
|
United States | 2 | 2017 | 69872 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2000 | 535 | 0.010 |
Why?
|
Cohort Studies | 1 | 2000 | 40561 | 0.010 |
Why?
|
Hindlimb | 1 | 1999 | 504 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1980 | 1801 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2002 | 714 | 0.010 |
Why?
|
Prospective Studies | 2 | 2011 | 53288 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2765 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2003 | 3144 | 0.010 |
Why?
|
Anticoagulants | 1 | 2011 | 4599 | 0.010 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2000 | 329 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2000 | 1586 | 0.010 |
Why?
|
Brain | 1 | 2002 | 26385 | 0.010 |
Why?
|
DNA Primers | 1 | 2000 | 2892 | 0.010 |
Why?
|
Plasmids | 1 | 2000 | 2307 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2000 | 1880 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2000 | 1117 | 0.010 |
Why?
|
Culture Media, Serum-Free | 1 | 1993 | 158 | 0.010 |
Why?
|
Rats | 3 | 1992 | 24260 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9313 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1783 | 0.010 |
Why?
|
Phenotype | 2 | 2007 | 16365 | 0.010 |
Why?
|
Pentetic Acid | 1 | 1993 | 213 | 0.010 |
Why?
|
Peroxides | 1 | 1993 | 74 | 0.010 |
Why?
|
Free Radicals | 1 | 1993 | 237 | 0.010 |
Why?
|
Tunica Intima | 1 | 1995 | 464 | 0.010 |
Why?
|
Free Radical Scavengers | 1 | 1993 | 216 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2004 | 3479 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2000 | 1889 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 13408 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 1992 | 292 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5097 | 0.010 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 1992 | 332 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2000 | 6171 | 0.010 |
Why?
|
Algorithms | 1 | 2011 | 13881 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 1992 | 331 | 0.010 |
Why?
|
Prevalence | 1 | 2006 | 15226 | 0.010 |
Why?
|
Smoking | 1 | 2006 | 8987 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2006 | 21746 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 2006 | 5751 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2012 | 57776 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1993 | 2187 | 0.000 |
Why?
|
Osteoblasts | 1 | 1992 | 1166 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1995 | 3206 | 0.000 |
Why?
|
Pituitary Gland | 1 | 1989 | 665 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1992 | 3701 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2006 | 25043 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2007 | 17446 | 0.000 |
Why?
|
Obesity | 1 | 2006 | 12745 | 0.000 |
Why?
|
Antibodies, Monoclonal | 1 | 2000 | 9274 | 0.000 |
Why?
|
Translocation, Genetic | 1 | 1989 | 1420 | 0.000 |
Why?
|
Aging | 1 | 1980 | 8664 | 0.000 |
Why?
|
Risk Factors | 1 | 2006 | 72290 | 0.000 |
Why?
|
Adolescent | 1 | 2005 | 85781 | 0.000 |
Why?
|